TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
BioNema AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,279
|
2,407
|
3,395 |
| Financial expenses |
2
|
5
|
1 |
| Earnings before taxes |
318
|
310
|
1,058 |
| EBITDA |
381
|
401
|
1,150 |
| Total assets |
2,473
|
2,152
|
2,555 |
| Current assets |
2,034
|
1,710
|
2,011 |
| Current liabilities |
310
|
184
|
486 |
| Equity capital |
2,163
|
1,968
|
1,955 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
87.5%
|
91.4%
|
76.5% |
| Turnover per employee |
1,640
|
1,204
|
1,698 |
| Profit as a percentage of turnover |
9.7%
|
12.9%
|
31.2% |
| Return on assets (ROA) |
12.9%
|
14.6%
|
41.4% |
| Current ratio |
656.1%
|
929.3%
|
413.8% |
| Return on equity (ROE) |
14.7%
|
15.8%
|
54.1% |
| Change turnover |
701
|
-885
|
-249 |
| Change turnover % |
27%
|
-27%
|
-7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.